CoChat

How common is hypoglycemia after gastric bypass?

Open access
Goldfine, Allison B., Patti, Mary Elizabeth · 2016 · Obesity
Cited by 38

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Bariatric surgery leads to substantial and sustained weight loss and resolution or improvements in type 2 diabetes, hypertension, and dyslipidemia. Cohort studies support improved longer-term mortality. Metabolic health improvements and safety vary with the specific bariatric surgery performed, likely a result of procedure-specific anatomic and physiologic changes. Recently, increased attention has been focused on a syndrome of hypoglycemia with neuroglycopenia observed most commonly following Roux-en-Y gastric bypass (RYGB), which typically first presents more than 1 to 2 years postoperatively and occurs predominantly in the postprandial state (1, 2). Post-bariatric hypoglycemia can be life threatening with altered consciousness, seizures, and motor vehicle accidents. Understanding the frequency of this syndrome and identifying which patients may be at risk is highly relevant given the large number of bariatric procedures performed worldwide. Lee et al. (3) now provide additional insights into the occurrence of post-RYGB hypoglycemia. The authors performed a retrospective survey of the bariatric registry and electronic medical records of Geisinger Health System, identifying a cohort of over 1,200 patients followed for a mean duration of 4.8 years postoperatively. Thirteen percent of patients without known preoperative hypoglycemia or diabetes met at least one criterion for hypoglycemia, including clinical diagnosis, laboratory glucose value <60 mg/dL [3.3 mmol/L], or new use of medication associated with treatment of hypoglycemia. Most of these patients met only one of these criteria. Notably, only 0.7% had evidence for more severe hypoglycemia, with documented laboratory glucose below 40 mg/dL [2.2 mmol/L], emergency room visit, or hospitalization for hypoglycemia. Clinical characteristics associated with incident hypoglycemia include modestly lower body mass index and HbA1c preoperatively, greater excess weight loss at 6 months, and longer duration of postoperative follow-up. Symptoms consistent with hypoglycemia may be even more prevalent, as up to one-third of patients completing a survey report some symptoms potentially consistent with hypoglycemia (4), although hypoglycemic symptoms are nonspecific and there can be reporting bias with those perceiving problems more likely to respond. While these data suggest mild hypoglycemia may be more frequent than recognized clinically, the long-term significance of mild hypoglycemia and accompanying increases in glycemic variability following RYGB remains unknown. Glycemic and hormonal profiles are modified in post-gastric bypass patients, with early peak of glucose and insulin after carbohydrate or mixed meal ingestion, in turn contributing to lower glucose concentrations in the later postprandial period (1, 5). Such metabolic profiles have been associated with dumping syndrome, which may occur in up to 70% of patients following RYGB after consuming high-glycemic-index carbohydrates; these symptoms are often responsive to dietary modification. However, a much smaller percentage of patients may develop severe hypoglycemia with neuroglycopenia. Metabolic studies in these severely affected patients demonstrate that both insulin-dependent and insulin-independent mechanisms may contribute to hypoglycemia (6). Notably, these patients are often incompletely responsive to medical nutritional therapy and require therapies aimed at slowing carbohydrate absorption with medical nutritional therapy or α-glucosidase inhibitors such as acarbose or suppression of insulin production using somatostatin analogues or diazoxide. Estimates of incidence of severe post-RYGB hypoglycemia differ, likely due to differences in definitions of severe hypoglycemia, patient selection criteria, and duration of follow-up, but are consistently <1% (Table 1). Studies utilizing continuous glucose monitoring suggest substantial hypoglycemia occurs even in completely asymptomatic patients post-RYGB, ranging from 29 to 71 min/day of sensor glucose values <60 mg/dL [3.3 mmol/L]; in one study, 75% of 40 unselected patients following RYGB had a sensor glucose value <55 mg/dL [3.1 mmol/L] (Table 1) compared with none in nonsurgical controls. Hypoglycemia during glucose or meal tolerance testing is also common (10–29%) after gastric bypass and can be observed after sleeve gastrectomy, but the physiologic relevance of asymptomatic hypoglycemia remains uncertain. The clinical relevance of severe hypoglycemia with neuroglycopenia is undeniable, as patient safety, cognition, and quality of life can be compromised. It remains plausible these individuals represent a spectrum of metabolic response or underlying susceptibility profiles not yet identified. Further understanding of the importance of glycemic variability or asymptomatic hypoglycemia in the postbariatric surgery setting and novel approaches to prevent severe hypoglycemia continue to merit further investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/oby.21520

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 38

Metadata

Authors
Goldfine, A. B., & Patti, M. E.
Venue
Obesity
Publisher
Wiley
Published
2016-05-25
Volume
24
Issue
6
Pages
1210-1211
ISSN
  • 1930-7381 (ISSN-L)
  • 1930-739X
OpenAlex
W2403784960
Cited by
38
References
3
FWCI
3.98
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.